Year: 2020
-
MSM ignores landmark ruling on PCR tests
The following article was written by Peter Andrews for RT and was published on November 27, 2020. In it Andrews summarizes some of the most important statements released by the Lisbon appeals court in relation to four German holidaymakers who were illegally quarantined by the Regional Health Authority [we have already published the ruling on…
-
Emergency approvals before end of clinical trials end could complicate efforts to study long-term effects of vaccine
With the proclamation of the success of the Pfizer and Moderna vaccines come the flurry of developers seeking emergency use approvals. In this article written by David Cyranoski for Nature, he discusses some of the concerns voiced out by various scientists: once the vaccines are approved for emergency use, they may compromise the ongoing trials…
-
Experts: Vaccines will cause side effects
In this November 23, 2020 article from CNN, members of the US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) say that Americans will need to be prepared for the possibility of side effects after getting the coronavirus vaccine. Experts say that vaccine providers must be ready to explain to…
-
Some countries have pre-ordered enough vaccines to immunize over 100% of their population
In this article for the World Economic Forum, Katherine Ellen Foley reports on the top countries that have pre-ordered vaccines. According to Foley’s report, the most preferred vaccines are that of Pfizer, Moderna, and the AstraZeneca-Oxford. As of writing, the European Union, US, India, Japan, and the UK have collectively reserved over 2 billion doses.…
-
Oxford-AstraZeneca vaccine delivers confusing results
This article published by Nature last November 23, 2020 raises concerns about the results of the clinical trials of the vaccine jointly developed by the University of Oxford and pharmaceutical AstraZeneca. Overall efficacy of the vaccine is reported at 70% effective, but scientists are seeing that there is a striking difference in the efficacy of…
-
Did We Forget Our Lessons from Dengvaxia?
The following article was written by Mauro Gia Samonte for The Manila Times and was published December 1, 2020. In this article, Samonte reminds us of the Philippines’ experience with Dengvaxia, a vaccine for Dengue developed by Sanofi for 20 years, tested on 30,000 children for 9 years, and said to be safe. After inoculating…
-
Kids develop coronavirus antibodies without testing positive
The following article published by Science Alert reports on the curious case of the Sawenko family, where parents got sick of COVID-19 while their children did not. The two boys, aged 9 and 7, had mild symptoms but their PCR tests were negative. Meanwhile, the 5-year old daughter, who co-slept with her parents showed no…
-
It’s time for an alternative to lockdown
The following article was written by Dr. Jay Bhattacharya for The Spectator. He says, “We should, in moments of crisis, be open to ideas about how best to handle it”. He says these words in the wake of various criticisms against The Great Barrington Declaration which he co-authors. He says that the proposal of the…
-
BMJ Editor: Science is being suppressed for political and financial gain
In this article for The BMJ (formerly the British Medical Journal), executive editor Kamran Abbasi reveals that politicians and governments are suppressing science through by “delaying publication, cherry picking favourable research, or gagging scientists”. This, he says is “state corruption on a grand scale, and it is harmful to public health”. Abbasi cites some examples…
-
Japan is experiencing a mental health epidemic
Japan has done well in keeping its COVID death toll below 2,000 nationwide, but deaths by suicide has continued to increase. A report published by CBS News shows that at the end of October, deaths by suicide has reached 2,153. 600 self-inflicted deaths were recorded in October alone, with female suicides accounting for 80% of…
